HK2 and hepatocellular carcinoma: Moreover, HK2 depletion was shown to promote cancer cell death and stimulated oxidative phosphorylation (Dewaal et al., 2018), revealing the importance of enhanced HK2 expression and indicating blocking HK2 may have important therapeutic impact for patients with HCC.